Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Albaha Barqawi

Concepts (147)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
14
2021
1004
1.960
Why?
Cryotherapy
3
2021
16
1.780
Why?
Prostate
3
2020
179
0.740
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2021
150
0.680
Why?
Imaging, Three-Dimensional
2
2020
563
0.580
Why?
Neoplasm Recurrence, Local
1
2020
959
0.460
Why?
Lower Urinary Tract Symptoms
1
2013
54
0.400
Why?
Symptom Assessment
1
2013
127
0.400
Why?
Ultrasound, High-Intensity Focused, Transrectal
1
2011
2
0.370
Why?
Prostate-Specific Antigen
6
2020
159
0.320
Why?
Ultrasonography, Interventional
2
2020
140
0.230
Why?
Self Medication
1
2004
10
0.230
Why?
Prazosin
1
2004
27
0.220
Why?
Plant Preparations
1
2004
31
0.220
Why?
Prostatic Hyperplasia
1
2004
42
0.220
Why?
Palpation
1
2003
11
0.220
Why?
Phytotherapy
1
2004
76
0.210
Why?
Cryptorchidism
1
2003
12
0.210
Why?
Anticarcinogenic Agents
1
2004
76
0.210
Why?
Complementary Therapies
1
2004
87
0.210
Why?
Testis
1
2003
143
0.200
Why?
Vitamins
1
2004
175
0.200
Why?
Combined Modality Therapy
2
2021
1219
0.190
Why?
Adenocarcinoma
2
2007
916
0.180
Why?
Neoplasm Staging
1
2004
1294
0.180
Why?
Kallikreins
1
2020
28
0.170
Why?
Image-Guided Biopsy
1
2020
37
0.170
Why?
Urination Disorders
2
2013
13
0.170
Why?
Dietary Supplements
1
2004
534
0.160
Why?
Male
17
2021
63748
0.160
Why?
Laparoscopy
1
2003
456
0.150
Why?
Middle Aged
9
2021
31322
0.140
Why?
Survival Rate
1
2021
1904
0.130
Why?
Mass Screening
1
2004
1139
0.130
Why?
Pilot Projects
1
2021
1565
0.130
Why?
Aged
8
2020
22282
0.120
Why?
Prospective Studies
2
2021
7131
0.120
Why?
Andropause
1
2013
7
0.110
Why?
Nocturia
1
2013
8
0.110
Why?
Antineoplastic Agents, Hormonal
2
2005
158
0.110
Why?
Humans
18
2021
130305
0.110
Why?
Case-Control Studies
1
2021
3369
0.110
Why?
Urology
1
2013
58
0.100
Why?
Dexamethasone
2
2006
337
0.100
Why?
Prognosis
1
2021
3830
0.100
Why?
Biopsy
2
2007
1107
0.100
Why?
Testosterone
2
2013
383
0.100
Why?
Follow-Up Studies
1
2021
4961
0.090
Why?
Quality of Life
2
2020
2735
0.080
Why?
Societies, Medical
1
2013
768
0.080
Why?
Retrospective Studies
4
2020
14675
0.080
Why?
Treatment Outcome
3
2020
10341
0.070
Why?
Androgen Antagonists
2
2006
78
0.070
Why?
Biopsy, Needle
1
2008
192
0.070
Why?
Patient Selection
1
2011
678
0.070
Why?
Prostatectomy
1
2007
105
0.070
Why?
Cryosurgery
1
2007
55
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2006
1579
0.060
Why?
Myocardial Infarction
1
2013
1036
0.060
Why?
Carboplatin
1
2006
140
0.060
Why?
Minimally Invasive Surgical Procedures
1
2007
175
0.060
Why?
Severity of Illness Index
1
2013
2785
0.060
Why?
Orchiectomy
1
2005
65
0.060
Why?
Stroke
1
2013
1119
0.060
Why?
Doxazosin
1
2004
3
0.060
Why?
Penile Erection
1
2004
7
0.060
Why?
Adrenergic alpha-Antagonists
1
2004
34
0.060
Why?
Finasteride
1
2004
37
0.060
Why?
Prostaglandin-Endoperoxide Synthases
1
2004
73
0.060
Why?
Selenium
1
2004
37
0.060
Why?
Early Diagnosis
1
2005
238
0.050
Why?
Seminal Vesicles
1
2003
9
0.050
Why?
Inguinal Canal
1
2003
10
0.050
Why?
Vas Deferens
1
2003
20
0.050
Why?
Peritoneal Cavity
1
2003
30
0.050
Why?
Patient Care Planning
1
2004
152
0.050
Why?
Gastroschisis
1
2003
21
0.050
Why?
Seminoma
1
2003
17
0.050
Why?
Anus, Imperforate
1
2003
24
0.050
Why?
Cyclooxygenase 2
1
2004
176
0.050
Why?
Radiation Injuries
1
2004
139
0.050
Why?
Cyclophosphamide
1
2003
232
0.050
Why?
Forecasting
1
2005
364
0.050
Why?
Isoenzymes
1
2004
305
0.050
Why?
Drug Utilization
1
2004
170
0.050
Why?
Hypospadias
1
2003
28
0.050
Why?
Ultrasonography
1
2007
731
0.050
Why?
Vitamin D
1
2006
386
0.050
Why?
Chromosome Aberrations
1
2003
149
0.050
Why?
Carcinoma
1
2004
218
0.050
Why?
United States
2
2013
14110
0.050
Why?
Testicular Neoplasms
1
2003
102
0.050
Why?
Urinary Bladder, Neurogenic
1
2002
35
0.050
Why?
Health Surveys
1
2004
495
0.050
Why?
Aged, 80 and over
3
2007
7128
0.040
Why?
Antioxidants
1
2004
562
0.040
Why?
Sulfonamides
1
2004
502
0.040
Why?
Socioeconomic Factors
1
2004
1200
0.040
Why?
Family
1
2004
656
0.040
Why?
Randomized Controlled Trials as Topic
1
2004
1381
0.040
Why?
Adult
3
2007
35711
0.040
Why?
Antibodies, Monoclonal
1
2004
1372
0.040
Why?
Research Design
1
2004
1052
0.040
Why?
Membrane Proteins
1
2004
1121
0.040
Why?
Oxidative Stress
1
2004
1239
0.030
Why?
Colorado
1
2004
4471
0.030
Why?
Antineoplastic Agents
1
2004
2078
0.030
Why?
Mortality
1
2013
310
0.020
Why?
Surveys and Questionnaires
1
2004
5400
0.020
Why?
Coronary Angiography
1
2013
345
0.020
Why?
Risk
1
2013
873
0.020
Why?
Risk Factors
1
2004
9865
0.020
Why?
Infant
1
2003
9049
0.020
Why?
Child, Preschool
1
2003
10514
0.020
Why?
Coronary Artery Disease
1
2013
697
0.020
Why?
Medical History Taking
1
2007
119
0.020
Why?
Child
2
2003
20961
0.020
Why?
Syndrome
1
2007
343
0.020
Why?
Image Interpretation, Computer-Assisted
1
2008
256
0.020
Why?
Pedigree
1
2007
493
0.020
Why?
Gynecomastia
1
2005
6
0.020
Why?
Sexual Dysfunction, Physiological
1
2005
67
0.010
Why?
Muscular Diseases
1
2005
110
0.010
Why?
Hot Flashes
1
2005
81
0.010
Why?
Trastuzumab
1
2004
100
0.010
Why?
Adolescent
1
2003
20374
0.010
Why?
Anemia
1
2005
156
0.010
Why?
Infusions, Intravenous
1
2004
395
0.010
Why?
In Situ Hybridization, Fluorescence
1
2004
323
0.010
Why?
Cohort Studies
1
2013
5431
0.010
Why?
Gastrointestinal Diseases
1
2005
201
0.010
Why?
Bladder Exstrophy
1
2002
16
0.010
Why?
Cystostomy
1
2002
9
0.010
Why?
Osteoporosis
1
2005
233
0.010
Why?
Receptor, ErbB-2
1
2004
337
0.010
Why?
Veterans
1
2013
1428
0.010
Why?
Urethra
1
2002
52
0.010
Why?
Animals
1
2004
35076
0.010
Why?
Neural Tube Defects
1
2002
63
0.010
Why?
Transplantation, Autologous
1
2002
215
0.010
Why?
Body Composition
1
2005
658
0.010
Why?
Spinal Dysraphism
1
2002
67
0.010
Why?
Immunohistochemistry
1
2004
1711
0.010
Why?
Drug Resistance, Neoplasm
1
2004
755
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2004
763
0.010
Why?
Disease Progression
1
2004
2639
0.010
Why?
Mental Disorders
1
2005
1032
0.010
Why?
Barqawi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)